Michael J. Cleare, Ph.D.

Mike Cleare worked for 30 years at Johnson Matthey, a UK-based multinational world leader in advanced materials technology. His experiences range from the Senior R&D Executive through Business Development to a range of senior business management positions, and included service on the main Board of the Company for four years. While in R&D Mike was involved in the discovery and development of a major new class of anti-cancer drugs (platinum based-particularly carboplatin). He served as President of several of the company's major divisions, including Pharmaceutical Materials, Chemicals and Metals, Catalytic Systems and Electronic Materials. He has managed complex global business, negotiated and closed multi-million dollar licensing and technology transfer deals, and entered into multiple research funding agreements with major universities.

From 2000-2007 Mike was the Executive Director of Science and Technology Ventures at Columbia University in New York. This position included responsibility for all technology transfer activities at Columbia and involved licensing, spin off/start up companies, industrial research funding and domestic and international partnerships relating to IP. He reported to the Senior Executive Vice President of Columbia.

In August 2007 Mike joined the University of Pennsylvania as Associate Vice Provost for Research, responsible for all technology transfer, IP management and industrial liasion activities.

For nine years, Mike was a member of the board of directors of the Canadian biotechnology company, AnorMed, which he helped to spin off from Johnson Matthey in 1996.

Mike holds a B. Sc., from MS Imperial College in London and a Ph.D. from London University.